Effect of a Structured Physical Exercise Program on Arteriovenous Fistula Maturation for Hemodialysis in Chronic Kidney Disease Patients
PEFAV
1 other identifier
interventional
128
1 country
1
Brief Summary
For patients living with Chronic Kidney Disease who are preparing to start hemodialysis, having a well-functioning arteriovenous fistula (AVF) is essential. Although the AVF is considered the best type of vascular access, its maturation process does not always go as expected-studies show that in 28% to 53% of cases, the fistula does not mature properly, making effective dialysis more difficult. There is growing interest in using physical exercise as a way to support AVF maturation. International guidelines even recommend arm exercises for this purpose. However, there is still no clear agreement on what type of exercise, how often, or how intense it should be. This study aims to evaluate whether a structured exercise program focused on the AVF arm can help improve the fistula's development and overall function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 16, 2025
CompletedFirst Submitted
Initial submission to the registry
April 15, 2025
CompletedFirst Posted
Study publicly available on registry
May 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedMay 7, 2025
April 1, 2025
12 months
April 15, 2025
May 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Evaluation of AVF maturation using clinical and ultrasound criteria: Diameter of the drainage vein (mm)
-Diameter of the drainage vein (mm). Eight weeks after the application of a physical exercise program, patients in the intervention and control groups will be evaluated through a physical examination (presence of thrill and continuous murmur, increased venous diameter, absence of complications such as stenosis or thrombosis) and ultrasound examination.
8 weeks
Evaluation of AVF maturation using clinical and ultrasound criteria: Venous wall thickness (mm)
\- Venous wall thickness (mm). Eight weeks after the application of a physical exercise program, patients in the intervention and control groups will be evaluated through a physical examination (presence of thrill and continuous murmur, increased venous diameter, absence of complications such as stenosis or thrombosis) and ultrasound examination.
8 weeks
Evaluation of AVF maturation using clinical and ultrasound criteria: Blood velocity (cm/sec)
\- Blood Velocity (cm/sec). Eight weeks after the application of a physical exercise program, patients in the intervention and control groups will be evaluated through a physical examination (presence of thrill and continuous murmur, increased venous diameter, absence of complications such as stenosis or thrombosis) and ultrasound examination.
8 weeks
Evaluation of AVF maturation using clinical and ultrasound criteria: Blood flow volume in the humeral artery (mL/min)
\- Blood flow volume in the humeral artery (mL/min). Eight weeks after the application of a physical exercise program, patients in the intervention and control groups will be evaluated through a physical examination (presence of thrill and continuous murmur, increased venous diameter, absence of complications such as stenosis or thrombosis) and ultrasound examination.
8 weeks
Secondary Outcomes (5)
Evaluation of the impact of each physical parameters in FAV maturation: Change in Handgrip Strength (kg)
8 weeks
Evaluation of the impact of each physical parameters in FAV maturation: Change in Forearm and Upper Arm Circumference (cm)
8 weeks
Evaluation of the impact of each physical parameters in FAV maturation: Change in Rate of AVF Complications (%)
8 weeks
Evaluation of the impact of each physical parameters in FAV maturation: Change in Blood Flow Velocity in the Humeral Artery (mL/min)
8 weeks
Evaluation of adherence Rate to the Exercise Program for the AVF Limb (%)
Within 7 weeks
Study Arms (2)
Exercised group
EXPERIMENTALThe participants in this group follow a structured physical exercise program for the arm with the Arteriovenous Fistula (AVF), including progressive exercises using weights and therapeutic balls. The goal is to assess the impact of this intervention on AVF maturation and functionality.
Control Group
NO INTERVENTIONThe participants in this group do not follow the exercise program and only receive the usual recommendations on AVF care (standard of care).
Interventions
Evaluation of AVF maturation using clinical and ultrasound criteria, after applying a structured physical exercise program.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- AVF in the upper limb
- No cognitive decline and ability to follow instructions
You may not qualify if:
- History of previous dysfunctional ipsilateral AVF
- History of injury/condition causing pain or loss of function in the AVF limb
- Musculoskeletal conditions/osteoarticular pathology (e.g., myopathy, rheumatoid arthritis)
- Neurological conditions/cardiovascular events (e.g., stroke, peripheral neuropathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unidade Local de Saude de Coimbra
Coimbra, Coimbra District, 3004-561, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ricardo A. S. Ferreira, Bachelor's degree in Nursing
Unidade Local de Saude de Coimbra
Central Study Contacts
Ricardo A. S. Ferreira, Bachelor's degree in Nursing
CONTACT
Clinical Trials Unit Unidade Local de Saude de Coimbra
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nephrology Nurse Ricardo Ferreira
Study Record Dates
First Submitted
April 15, 2025
First Posted
May 7, 2025
Study Start
January 16, 2025
Primary Completion
December 31, 2025
Study Completion (Estimated)
June 30, 2026
Last Updated
May 7, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Data will be irreversibly anonymized and exclusively handled by researchers involved in the study.